Microbiologists improve taste of beer
Belgian investigators have improved the flavor of contemporary beer by identifying and engineering a gene that is responsible for much of the flavor of beer and some other alcoholic drinks. The research appears in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.
symbol picture
Computer generated picture
For centuries, beer was brewed in open, horizontal vats. But in the 1970s, the industry switched to using large, closed vessels, which are much easier to fill, empty, and clean, enabling brewing of larger volumes and reducing costs. However, these modern methods produced inferior quality beer, due to insufficient flavor production.
During fermentation, yeast converts 50 percent of the sugar in the mash to ethanol, and the other 50 percent to carbon dioxide. The problem: the carbon dioxide pressurizes these closed vessels, dampening flavor.
Johan Thevelein, Ph.D., an emeritus professor of Molecular Cell Biology at Katholieke Universiteit, and his team had pioneered technology for identifying genes responsible for commercially important traits in yeast. They applied this technology to identify the gene(s) responsible for flavor in beer, by screening large numbers of yeast strains to evaluate which did the best job of preserving flavor under pressure. They focused on a gene for a banana-like flavor “because it is one of the most important flavors present in beer, as well as in other alcoholic drinks,” said Thevelein, who is also founder of NovelYeast, which collaborates with other companies in industrial biotechnology.
“To our surprise, we identified a single mutation in the MDS3 gene, which codes for a regulator apparently involved in production of isoamyl acetate, the source of the banana-like flavor that was responsible for most of the pressure tolerance in this specific yeast strain,” said Thevelein.
Thevelein and coworkers then used CRISPR/Cas9, a revolutionary gene editing technology, to engineer this mutation in other brewing strains, which similarly improved their tolerance of carbon dioxide pressure, enabling full flavor. “That demonstrated the scientific relevance of our findings, and their commercial potential,” said Thevelein.
“The mutation is the first insight into understanding the mechanism by which high carbon dioxide pressure may compromise beer flavor production,” said Thevelein, who noted that the MDS3 protein is likely a component of an important regulatory pathway that may play a role in carbon dioxide inhibition of banana flavor production, adding, “how it does that is not clear.”
The technology has also been successful in identifying genetic elements important for rose flavor production by yeast in alcoholic drinks, as well as other commercially important traits, such as glycerol production and thermotolerance.
Original publication
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Catalyst to make renewable paints, coatings, and diapers discovered - Groundbreaking discovery will enable the manufacturing of biorenewable materials from trees and corn: A Startup wants to make it possible
Zealand Pharma and Helsinn announce the advance of elsiglutide into Phase II for the prevention of chemotherapy-induced diarrhea in cancer patients - First patients dosed in Phase IIa study of novel GLP-2 peptide agonist
Alzheimer’s: modulation of cell membrane influences formation of amyloid-β - Adding long-chain fatty acids can thicken cell membranes and alter the activity of a key enzyme
Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines
Agilent Technologies Opens Global Manufacturing Facility for Life Sciences Instruments
New targeting opportunities discovered against canine distemper virus - Structure of the canine distemper virus "docking protein" determined and depicted it at molecular level for the first time - and this can also help with measles
Ion channel VRAC enhances immune response against viruses - New strategies against DNA viruses and cancer
Novartis study showed ACZ885 provided substantial symptom relief in 84% of patients with the most serious form of childhood arthritis - Second pivotal Phase III trial ongoing; worldwide regulatory submissions planned for 2012
Organ bioprinting gets a breath of fresh air - Bioengineers clear major hurdle on path to 3D printing replacement organs
Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University
